2022
- Space Flight-Promoted Insulin Resistance as a Possible Disruptor of Wound Healing
- The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study
- Comparison between Policaptil Gel Retard and Metformin by Testing of Temporal Changes in Patients with Metabolic Syndrome and Type 2 Diabetes
- Genital Infection Risk Profile in Post-menopausal Women with Type 2 Diabetes Mellitus on Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
- Comment on the article Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes
- Kidney and lung in pathology: mechanisms and clinical implications
- Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients
F. Strollo 1*, S. Gentile2, A. M. V. Pipicelli 3, A. Mambro4, M. Monici5 and P. Magni6,7
1Endocrinology and Metabolism Unit, IRCCS San Raffaele Pisana, Rome, Italy, 2Department of Internal Medicine, Campania
University “Luigi Vanvitelli”, Naples, Italy and Nefrocenter Research Network, Naples, Italy, 3Nephrology, Dialysis and Transplant
Unit, Medical and Surgical Sciences Department, “A. Gemelli” Sacred Heart Catholic University, Rome, Italy, 4Anesthesiology and
Intensive Care Unit, Pertini General Hospital, Rome, Italy, 5Department of Experimental and Clinical Biomedical Sciences “Mario
Serio”, ASA Campus Joint Laboratory, ASA Res. Div, University of Florence, Florence, Italy, 6Department of Pharmacological and
Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy, 7IRCCS Multimedica Hospital, Sesto San Giovanni, Milan,
Italy
Sandro Gentile . Giuseppina Guarino . Teresa Della Corte . Giampiero Marino . Ersilia Satta .
Maria Pasquarella . Carmine Romano . Carmelo Alfrone . Laura Giordano . Fabrizio Loiacono .
Maurizio Capece . Rossella Lamberti . Felice Strollo on behalf of Nefrocenter and Nyx Start-up, AMDOSDI
Study Group on Injection Techniques, and ANIAD
S. Gentile G. Guarino T. Della Corte E. Satta
M. Pasquarella C. Romano C. Alfrone
Nefrocenter Research and Nyx Start-Up, Naples,
Italy
S. Gentile G. Guarino T. Della Corte G. Marino
Department of Internal Medicine, Campania
University ‘‘Luigi Vanvitelli’’, Naples, Italy
E. Satta
Polyspecialistic Nephrologic Center CNP Srl, Fratta
Maggiore, Italy
L. Giordano
Emodialysis Center Srl, Nefrocenter Network,
Naples, Italy
F. Loiacono
Nefrocenter Research, Naples, Italy
M. Capece
Vomero Center Crisci Bersabea & C SNC,
Nefrocenter Network, Naples, Italy
R. Lamberti
Metelliano Medical Center, Nefrocenter Network,
Naples, Italy
F. Strollo (&)
Endocrinology and Diabetes, IRCCS San Raffaele
Pisana, Rome, Italy
e-mail: felix.strollo@gmail.com
Giuseppina Guarino 1, Felice Strollo 2, Teresa Della-Corte 1,3,* , Ersilia Satta 3, Carmine Romano 3, Carmelo Alfarone 4, Gerardo Corigliano 5, Marco Corigliano 6, Giuseppe Cozzolino 7, Clementina Brancario 7, Carmine Martino 8, Domenica Oliva 9, Agostino Vecchiato 10, Clelia Lamberti 10, Luca Franco 8 and Sandro Gentile 3
1 Departement of Internal Medicine, Campania University “Luigi Vanvitelli”, 80131 Naples, Italy;
giuseppina.guarino@unicampania.it
2 Endocrinology and Diabetes, San Raffaele Pisana Research Institute, 00163 Rome, Italy;
felix.strollo@gmail.com
3 Nefrocenter Research Network & Nyx Research Start-Up, 84013 Naples, Italy; e.satta@nefrocenter.it (E.S.);
croman@libero.it (C.R.); s.gentile1949@gmail.com (S.G.)
4 Nefrocenter Research Network, Diagest Dialysis Unit, 00100 Rome, Italy; carmelo.alfarone@diagest.it
5 Diabetes Unit AID Napoli, 80121 Naples, Italy; gcorigliano@virgilio.it
6 Diabetes Unit AID Oplonti, Torre Annunziata, 80058 Naples, Italy; mcorigliano@inwind.it
7 Diabetes Unit AID Nola, 80035 Nola, Italy; gcozzolino@libero.it (G.C.); clementina.brancario@alice.it (C.B.)
8 Diabetes Unit AID Castellammare di Stabia, 80053 Castellammare di Stabia, Italy;
carminemartino@msn.com (C.M.); luca.francomd@gmail.com (L.F.)
9 Diabetes Unit AID Cava de’ Tirreni, 84013 Cava de’ Tirreni, Italy; domenica_oliva@libero.it
10 Diabetes Unit AID Nocera Inferiore, 84014 Nocera Inferiore, Italy; a.vecchiato@gmail.com (A.V.);
cleo.lamberti@libero.it (C.L.)
* Correspondence: tere.dellacorte@gmail.com
Genital Infection Risk Profile in Post-menopausal Women with Type 2 Diabetes Mellitus on Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Gentile S1,2, Guarino G1, Della Corte T1,2, Satta E2-4, Pipicelli AMV5, Romano C2, Alfarone C2, Lamberti R6, Di Maio A6 and Strollo F7*
1Campania University “Luigi Vanvitelli”, Naples, Italy
2Nefrocenter Research and Nyx Start-UP, Naples, Italy
3Haemodialysis Center s.r.l. Nefrocenter Network, Naples, Italy
4Polyspecialist Nephrology Center CNP Srl, Nefrocenter Network SRL,
Frattamaggiore, Italy
5Nephrology, Dialysis and Transplant Unit, Medical and Surgical Science
Department, “A. Gemelli” University Polyclinic IRCCS Foundation, Catholic
University of the Sacred Heart, Rome, Italy
6Metelliano Medical Center, Nefrocenter Network, Naples, Italy
7IRCCS San Raffaele Pisana, Rome, Italy
*Corresponding Author: Strollo F, IRCCS San Raffaele Pisana, Rome, Italy.
Email: felix.strollo@gmail.com
Comment on the article “Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes”
S. Gentile, G. Guarino, E. Satta et al., Comment on the article Determination of insulin related lipohypertrophy frequency and risk factors in patients with diabetes, Endocrinología, Diabetes y Nutrición,
References1. Korkmaz FN, Canpolat GA, Güllü S. Determination of insulin-related lipohypertrophy frequency and risk factors in patient swith diabetes Determinación de la frecuencia y los factores de riesgo de la lipohipertrofia relacionada con la insulina en pacientes con diabetes. Endocrinol Diab y Nutrición. 2021,http://dx.doi.org/10.1016/j.endinu.2021.07.002. First online25 August.
2. Gentile S, Strollo F, Guarino G. Diabetologists; nurses. Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest? Diabetes Metab Syndr. 2019;13(1):682—6,http://dx.doi.org/10.1016/j.dsx.2018.11.042. Epub 2018 Nov16. PMID: 30641790.
3. Gentile S, Strollo F, Della Corte T, Marino G, GuarinoG. Insulin related lipodystrophic lesions and hypoglycemia:Double standards? Diabetes Metab Syndr. 2018;12(5):813—8,http://dx.doi.org/10.1016/j.dsx.2018.04.023. Epub 2018 Apr10. PMID: 29703450.
4. Ansari AM, Osmani L, Matsangos AE, Li QK. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.Pathol Res Pract. 2017;213(10):1237—41, http://dx.doi.org/10.1016/j.prp.2017.08.013. Epub 2017 Sep 1. PMID: 28935176.
5. Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, HirschLJ, et al. New insulin delivery recommendations. MayoClin Proc. 2016;91(9):1231—55, http://dx.doi.org/10.1016/j.mayocp.2016.06.010. PMID: 27594187.
6. Blanco M, Hernandez MT, Strauss KW, Amaya M. Prevalence andrisk factors of lipohypertrophy in insulin-injecting patients withdiabetes. Diabetes Metab. 2013;39:445—50.
7. Gentile S, Guarino G, Della Corte T, Marino G, Satta E,Pasquarella M, et al. The durability of an intensive structurededucation-based rehabilitation protocol for best insulin injectionpractice: the ISTERP-2 study. Diabetes Ther. 2021;12(9):2557—69,http://dx.doi.org/10.1007/s13300-021-01108-9. PMID: Epub2021 Aug 12. PMID: 34383261.
Sandro Gentilea,b,∗, Giuseppina Guarinoa, Ersilia Sattab,Felice StrollocaVanvitelli University, School of Medicine, Naples, ItalybNefrocenter Research and Nyx Start-up, Naples, ItalycIRCCS San Raffaele Pisana, Rome, Italy∗
Corresponding author.E-mail address: s.gentile1949@gmail.com (S. Gentile).2
https://doi.org/10.1016/j.endinu.2021.09.016
Acknowledgment: Special thanks are due to Paola Murano for her complimentary editorial assistance.
Kidney and lung in pathology: mechanisms and clinical implications
Ersilia Satta,1 Carmelo Alfarone,2 Alfonso De Maio,3 Sandro Gentile,1 Carmine Romano,1 Mario Polverino,1 Francesca Polverino4
1Nefrocenter Research S.c.arl, Cava de’ Tirreni (SA), Italy
2Betadial Srl, Dialysis Center, Nefrocenter, Cava de’ Tirreni (SA), Italy
3CMM Srl, Dialysis Center, Nefrocenter, Cava de’ Tirreni (SA), Italy
4Asthma and Airway Disease Research Center, Department of Medicine, University of Arizona, Tucson, AZ, USA
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients
Guido Gembillo1,2 Rossella Siligato1 Valeria Cernaro1 Ersilia Satta2 Giovanni Conti3 Antonino Salvo1 Adolfo Romeo1 Vincenzo Calabrese1 Giovanna Sposito4,5 Guido Ferlazzo4,5 Domenico Santoro1
1 Unit of Nephrology and Dialysis, Department of Clinical
and Experimental Medicine, University of Messina, Via
Consolare Valeria, 98125 Messina, Italy
2 Department of Biomedical, Dental, Morphological
and Functional Imaging Sciences, University of Messina,
Messina, Italy
3 Nefrocenter Research Network, Naples, Italy
4 Pediatric Nephrology Unit, AOU Policlinic “G Martino”,
University of Messina, 98125 Messina, Italy
5 Laboratory of Immunology and Biotherapy, Department
of Human Pathology, University of Messina, Messina, Italy